INIS
drugs
100%
brain
78%
nanoparticles
73%
bacteria
66%
toxicity
58%
cysts
56%
host
53%
genotype
50%
pathogens
45%
molecules
43%
humans
43%
environment
42%
central nervous system
41%
diseases
39%
in vitro
31%
cancer
31%
silver
30%
amoeba
30%
water
29%
encephalitis
29%
lenses
29%
human cells
28%
animals
28%
viability
26%
pathogenesis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amoeba (Life Cycle Stage)
78%
Antiinfective Agent
60%
Acanthamoeba castellanii
48%
Infection
47%
Acanthamoeba
41%
Naegleria fowleri
37%
Nanoparticle
33%
Antiamoebic
31%
Silver Nanoparticle
30%
Cytotoxicity
28%
Balamuthia mandrillaris
24%
Antibacterial Activity
23%
Infectious Agent
22%
Intestine Flora
21%
Immunology and Microbiology
Acanthamoeba
85%
Acanthamoeba castellanii
62%
Cytotoxicity
41%
Infectious Agent
34%
Naegleria fowleri
25%
Trophozoite
24%
Intestine Flora
24%
Host Cell
23%
Balamuthia mandrillaris
23%
Escherichia coli
20%